ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202 | -18.9% | 37,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $249 | -24.1% | 37,100 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $328 | +15.9% | 37,100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $283 | -99.8% | 37,100 | +71.8% | 0.00% | +100.0% |
| Q3 2022 | $154,000 | -12.0% | 21,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $175,000 | -41.7% | 21,600 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $300,000 | -50.5% | 21,600 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $606,000 | -17.4% | 21,600 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $734,000 | -16.9% | 21,600 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $883,000 | +2.9% | 21,600 | +1.4% | 0.01% | 0.0% |
| Q1 2021 | $858,000 | -16.6% | 21,300 | +22.4% | 0.01% | -16.7% |
| Q4 2020 | $1,029,000 | +21.6% | 17,400 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $846,000 | -55.4% | 17,400 | -55.6% | 0.01% | -25.0% |
| Q2 2020 | $1,896,000 | – | 39,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |